Open Journal of Rheumatology and Autoimmune Diseases
Vol.3 No.3(2013), Paper ID 35919, 6
pages
DOI:10.4236/ojra.2013.33024
A Composite Endpoint Measure to Consolidate Multidimensional Impact of Treatment on Gouty Arthritis
Andrew J. Sarkin, Ari Gnanasakthy, Rachel S. Lale, Kyle J. Choi, Jan D. Hirsch
Health Services Research Center, University of California, San Diego, USA
Novartis Pharmaceuticals Corporation, East Hanover, USA
Health Services Research Center, University of California, San Diego, USA
Health Services Research Center, University of California, San Diego, USA
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, USA
Copyright © 2013 Andrew J. Sarkin, Ari Gnanasakthy, Rachel S. Lale, Kyle J. Choi, Jan D. Hirsch et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Sarkin, A. , Gnanasakthy, A. , Lale, R. , Choi, K. and Hirsch, J. (2013) A Composite Endpoint Measure to Consolidate Multidimensional Impact of Treatment on Gouty Arthritis.
Open Journal of Rheumatology and Autoimmune Diseases,
3, 159-164. doi:
10.4236/ojra.2013.33024.